16505422

Source:http://linkedlifedata.com/resource/pubmed/id/16505422

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013216, umls-concept:C0019929, umls-concept:C0080103, umls-concept:C0205225, umls-concept:C0220901, umls-concept:C0449438, umls-concept:C0677874, umls-concept:C1521733, umls-concept:C1521761, umls-concept:C1522609, umls-concept:C1554112
pubmed:issue	7
pubmed:dateCreated	2006-2-28
pubmed:abstractText	To evaluate whether hormonal receptor (HR) status can influence the prognostic significance of pathologic complete response (pCR).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anthracyclines, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Progesterone, http://linkedlifedata.com/resource/pubmed/chemical/Taxoids, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	1527-7755
pubmed:author	pubmed-author:BroglioKristineK, pubmed-author:BuchholzThomasT, pubmed-author:BuzdarAman UAU, pubmed-author:CristofanilliMassimoM, pubmed-author:Gonzalez-AnguloAna MAM, pubmed-author:GuarneriValentinaV, pubmed-author:HortobagyiGabriel NGN, pubmed-author:KauShu-WanSW, pubmed-author:MericFundaF, pubmed-author:MiddletonLaviniaL, pubmed-author:ValeroVicenteV
pubmed:issnType	Electronic
pubmed:day	1
pubmed:volume	24
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1037-44
pubmed:dateRevised	2009-11-19
pubmed:meshHeading	pubmed-meshheading:16505422-Adult, pubmed-meshheading:16505422-Aged, pubmed-meshheading:16505422-Aged, 80 and over, pubmed-meshheading:16505422-Anthracyclines, pubmed-meshheading:16505422-Antineoplastic Agents, pubmed-meshheading:16505422-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:16505422-Breast Neoplasms, pubmed-meshheading:16505422-Female, pubmed-meshheading:16505422-Humans, pubmed-meshheading:16505422-Middle Aged, pubmed-meshheading:16505422-Predictive Value of Tests, pubmed-meshheading:16505422-Prognosis, pubmed-meshheading:16505422-Proportional Hazards Models, pubmed-meshheading:16505422-Receptor, erbB-2, pubmed-meshheading:16505422-Receptors, Estrogen, pubmed-meshheading:16505422-Receptors, Progesterone, pubmed-meshheading:16505422-Retrospective Studies, pubmed-meshheading:16505422-Survival Analysis, pubmed-meshheading:16505422-Taxoids, pubmed-meshheading:16505422-Tumor Markers, Biological
pubmed:year	2006
pubmed:articleTitle	Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors.
pubmed:affiliation	Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77230-1439, USA.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't